Clinical Trials
161 trialsNIKOLE
Spanish Breast Cancer Research Group
COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation
Eastern Cooperative Oncology Group
Multiparametric MRI for Assessing Breast Cancer Response to Anti-HER2 Therapy
University of Washington
Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women
Mayo Clinic
Quality of Life in Breast Cancer Survivors Who Were Pregnant During Their Cancer Treatment
M.D. Anderson Cancer Center
Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening
University of Chicago
Impact of Sequential Chemotherapy on Young Patients Breast Cancer Treated Fertility
Centre Oscar Lambret
MIMIR-mTNBC
Karolinska University Hospital
DWIBS
Baylor Research Institute
PROTECT-COEUR
Institut de cancérologie Strasbourg Europe
PROTECT-06-bis
Institut de cancérologie Strasbourg Europe
TAM
University of Pennsylvania
A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women, and Men, With HR+,HER2- , Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation, After Disease Progression Following Endocrine Therapy as Monotherapy, in the Real-world Setting
Novartis
YASU Research Registry: For Young Adults With Cancer
Young Adult Survivors United
PEAR-TNBC
Ourotech, Inc.
CharactHer. ICORG 12-09, V3
Cancer Trials Ireland
Ovarian Reserve in Premenopausal Breast Cancer
Cancer Trials Ireland
START
Lyell Immunopharma, Inc.
Prognostic Indicators for Radiation-induced Breast Fibrosis
AHS Cancer Control Alberta
Relationship Between Alterations in the GI Microbiome and GI Inflammation on Symptom Burden in Women With Breast Cancer Receiving Chemotherapy
Mayo Clinic
Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors
National Institutes of Health Clinical Center (CC)
Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer
Mayo Clinic
Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil
AstraZeneca
High Resolution 3D Diffusion-weighted Breast MRI
Stanford University
Using Imaging Data and Genomic Data to Predict Metastasis of Breast Cancer After Treatment
Chinese University of Hong Kong
Evaluation of Mammographic Breast Density in Participants with Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Alliance for Clinical Trials in Oncology
ABCD
Sanford Health
DB RESPOND
AstraZeneca
PBI Registry
Wake Forest University Health Sciences
Novel Thermal Imaging Technique for Breast Screening
University of Arizona
Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone
Wake Forest University Health Sciences
Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
M.D. Anderson Cancer Center
Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer.
BioCorteX Inc
Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients
GE Healthcare
Organoid Model Predictive of Response to Immunotherapies
Indiana University
Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy
University of Wisconsin, Madison
Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer
AHS Cancer Control Alberta
A Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Breast Cancer
Duke University
Dedicated Breast CT for Diagnosis of Breast Cancer
Radboud University Medical Center
MINDACTRelapse
European Organisation for Research and Treatment of Cancer - EORTC
Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Dissection
Johns Hopkins University
A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BC
Samsung Bioepis Co., Ltd.
OVA360
Aspira Women's Health
Detection of Breast Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC
HKGepitherapeutics
Photoacoustic Lymph Node Imaging
Dartmouth-Hitchcock Medical Center
SENSE
Sapere Bio
Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer
National Institutes of Health Clinical Center (CC)
FORESEE
Biocept, Inc.
Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer
University of Michigan Rogel Cancer Center
Study of KN026 in Combination With Palbociclib and Fulvestrant in Patients With Advanced Breast Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd